Posted in | News | Military Robotics

RE2 to Develop Robotic Controller with Dual Arms

RE2, a developer of Intelligent Modular Manipulation Systems, has declared that the Office of Naval Research has awarded a three year $1.1 million Broad Agency Announcement Contract (BAA) for developing a dual-arm robotic controller for operations involving Explosive Ordinance Disposal (EOD).

These robotic systems would incorporate two very dexterous arms containing added sensing powers such as force feedback. To utilize the advanced capacities of the robotic manipulators, the operator control station must also be upgraded simultaneously.

According to Dr. Patrick Rowe, who is RE2’s Vice President of R & D, a robotic manipulator could be effective, only if the operator has the capability to control it. This program’s chief goal was to endow the robot operators with the skill and capacity to perform complicated manipulation tasks, much above the current available levels. Jorgen Pedersen, the CEO and President of RE2 stated that the EOD operators have long been asking for dual armed and user friendly robots, and with this contract RE2 would use its expertise in robotic manipulation to find a solution to this challenge. He also revealed that this contract would help the company progress and grow.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Choi, Andy. (2019, February 21). RE2 to Develop Robotic Controller with Dual Arms. AZoRobotics. Retrieved on May 30, 2024 from

  • MLA

    Choi, Andy. "RE2 to Develop Robotic Controller with Dual Arms". AZoRobotics. 30 May 2024. <>.

  • Chicago

    Choi, Andy. "RE2 to Develop Robotic Controller with Dual Arms". AZoRobotics. (accessed May 30, 2024).

  • Harvard

    Choi, Andy. 2019. RE2 to Develop Robotic Controller with Dual Arms. AZoRobotics, viewed 30 May 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.